Semaglutide (Wegovy) a GLP-1 receptor agonist available on the NHS through specialist weight management services for eligible patients, in line with NICE TA875
It does not describe human use, animal use, medical outcomes, treatment effects, prevention effects, cosmetic effects, skin-related effects, anti-aging effects, recovery effects, or personal-use applications
With prescription GHK-Cu injectables , your exact dosage and protocol will depend on your therapeutic goal
These jabs are often heralded as a fast-acting way to combat profound fatigue
Always verify diluent compatibility for the specific peptide you are working with
If your symptoms return before your next scheduled dose, that is a conversation for your GP, not a cue to add unrecorded top-ups